Search Results
Results found for "Haicang Zhang"
- Accelerating GPCR Drug Discovery
Traditional roles rarely gave me the freedom to implement these changes at the scale needed.
- Identification and functional characterization of the sulfakinin and sulfakinin receptor in the...
expression levels of the two genes were different between male and female adults, and there were significant changes
- đ° GPCR Weekly News, February 27 to March 5, 2023
Keep in mind that you can always change your email preferences in your account settings. GPCRs in Neuroscience Physiological Condition Dependent Changes in Ciliary GPCR Localization in the Brain
- Orthosteric vs Allosteric Interactionsâ and the pHSense Shift in Internalization
âYouâre not changing the spectrum,â Trinquet explains. âYouâre changing how bright it isâand how long it glows.â
- In vitro assays for the functional characterization of (psychedelic) substances at the serotonin...
assays to monitor β-arrestin recruitment or signaling, and assays to monitor receptor conformational changes
- Combined docking and machine learning identify key molecular determinants of ligand pharmacological
allowed us to construct an exquisitely detailed structureâactivity relationship that identifies small changes
- Effect Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells
this study, we investigated the effects of THC and CBD on the differentiation of MECs by assessing changes
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⌿ Oct 28 - Nov 3, 2024
Ya-Tzu Li , our notable contributor, for her superb undergrad paper along with Hao-Jen Hsu , Chun-Chun Chang Drugs like Ozempic will change the world GPCR Events, Meetings, and Webinars November 5 - 7, 2024 | 16th
- Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1
as this was the first description of ACKR1 expression by any leukocyte type and, if correct, would change
- GPCR Happy Hour â Boston, Sept 2025
America, NIS delivers cutting-edge imaging and analysis that accelerates the discovery of new and life-changing
- Beyond HEK293 â Terry HĂŠbert on iPSC-Derived GPCR Models, Live April 16,
This week's session examines what changes when you close that gap. Terry HĂŠbert joins the Dr.
- Biphasic activation of β-arrestin 1 upon interaction with a GPCR revealed by methyl-TROSY NMR
Here, we show the conformational changes for βarr activation upon the C tail- and TM core-mediated interactions
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
The changes in amyloid pathology are accompanied by robust microglial and astrocytic hypertrophy, which
- Phospholipid Scrambling by G Protein-Coupled Receptors
Conformational changes that facilitate scrambling are distinct from those associated with GPCR signaling
- Canonical chemokine receptors as scavenging âdecoysâ
2000), becoming incapable of promoting cell migration, a phenomenon which is likely to be mediated by changes
- Newly launched antibody libraries put hard-to-drug targets within reach
The drugs also target relatively low-hanging fruit: like cytokines or tyrosine kinase receptors.
- How Fast Does a Drug Work?
Competitive conditions âsuch as the presence of endogenous ligandsâ change kinetic behavior , and ignoring
- Radioligands vs. Fluorescent Ligands: Binding Assays
with a higher specific activity, but a shorter half-life (60 days), which complicates storage, besides changing
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
Why this matters: Membrane context changes signaling outcomes.
- Ode to GPCRs
Zhang, X. & Eggert, U. S.
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
/no-go choices Strategic insights into early identification and mitigation of drug liabilities Game-Changing
- GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between ...
molecular diversity of GPCR signaling systems is likely to be closely associated with disease-associated changes
- How Schild Analysis Protects Your Conclusions in GPCR Research
Anyone who joins before the change is fully grandfathered  â your rate stays locked, and your whole team
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
Target EngagementâDonât Chase It with Irreversible Drugs When binding outlives exposure, everything changes
- G protein-coupled receptor interactions and modification of signalling involving the ghrelin ...
In all cases, the receptor interaction changes downstream signalling and the responses to receptor agonists
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
Structural analysis of SMO domains shows significant changes in the CRD and ICD, during the course of
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
. đ§ Go behind the scenes with Revvity âfrom the chemistry to the critical moments that changed everything
- GPCR Internalization: When the Signal Moves Inside the Cell
The receptor does not require a classical agonist-induced conformational change to leave the cell surface
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
Every time a problem arises, we trace it back to its root cause, implementing changes that prevent its
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
Crucially, altering one does not inherently change the othersâa principle often overlooked in early discovery















